Incidence, serum IgE and TARC/ccl17 levels in atopic dermatitis associated with other allergic diseases: An update from the Ishigaki cohort

Acta Dermato-Venereologica

Volumn 95, Issue 4, 2015, Pages 480-484

  Takeuchi, Satosh ^a,b   Esaki, Hitokaz ^a   Furusyo, Norihir ^a,c   Hayashida, Sayak ^a   Yamamura, Kazuhik ^a   Tsuji, Gak ^a   Takemura, Masak ^a   Hayashi, Jun ^a,c   Furue, Masutak ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HAMANOMACHI HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Atopic dermatitis; Cohort; Epidemiology; Incidence; Prevalence

Indexed keywords

IMMUNOGLOBULIN E; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CCL17 PROTEIN, HUMAN;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BLOOD SAMPLING; CHILD; COHORT ANALYSIS; DERMATOLOGIST; DISEASE ASSOCIATION; DISEASE SEVERITY; EGG ALLERGY; FEMALE; FOOD ALLERGY; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STRUCTURED QUESTIONNAIRE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; DERMATITIS, ATOPIC; EGG HYPERSENSITIVITY; GENETIC PREDISPOSITION; PRESCHOOL CHILD; RHINITIS, ALLERGIC; SEVERITY OF ILLNESS INDEX;

ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; CHEMOKINE CCL17; CHILD, PRESCHOOL; COHORT STUDIES; DERMATITIS, ATOPIC; EGG HYPERSENSITIVITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN E; INCIDENCE; JAPAN; MALE; PREVALENCE; RHINITIS, ALLERGIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84924953947     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1989     Document Type: Article

References (19)

1. Williams HC. Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol 1992; 17: 385–391.
2. Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103: 125–138.
3. Takeuchi M, Ueda H. Increase of adult atopic dermatitis (AD) in recent Japan. Environ Dermatol 2000; 7: 133–136.
4. Sugiura H, Umemoto N, Deguchi H, Murata Y, Tanaka K, Sawai T, et al. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago. Acta Derm Venereol 1998; 78: 293–294.
5. Maksimović N, Janković S, Marinković J, Sekulović LK, Zivković Z, Spirić VT. Health-related quality of life in patients with atopic dermatitis. J Dermatol 2012; 39: 42–47.
6. Hamada M, Furusyo N, Urabe K, Morita K, Nakahara T, Kinukawa N, et al. Prevalence of atopic dermatitis and serum IgE values in nursery school children in Ishigaki Island, Okinawa, Japan. J Dermatol 2005; 32: 248–255.
7. Fukiwake N, Furusyo N, Kubo N, Takeoka H, Toyoda K, Morita K, et al. Incidence of atopic dermatitis in nursery school children – a follow-up study from 2001 to 2004, Kyushu University Ishigaki Atopic Dermatitis Study (KIDS). Eur J Dermatol 2006; 16: 416–419.
8. Fukiwake N, Furusyo N, Takeoka H, Toyoda K, Kubo N, Kido M, et al. Association factors for atopic dermatitis in nursery school children in Ishigaki islands – Kyushu University Ishigaki Atopic Dermatitis Study (KIDS). Eur J Dermatol 2008; 18: 571–574.
9. Furusyo N, Takeoka H, Toyoda K, Murata M, Maeda S, Ohnishi H, et al. Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS). Eur J Dermatol 2007; 17: 397–404.
10. Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I, et al. Guidelines for management of atopic dermatitis. J Dermatol 2009; 36: 563–577.
11. Yamamoto S. Prevalence and exacerbation factors of atopic dermatitis. Skin Allergy Frontier 2003; 1: 85–90.
12. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441–446.
13. Tan SP, Abdul-Ghaffar S, Weller RB, Brown SB. Proteaseantiprotease imbalance may be linked to potential defects in profilaggrin proteolysis in atopic dermatitis. Br J Dermatol 2012; 166: 1137–1140.
14. Sasaki T, Furusyo N, Shiohama A, Takeuchi S, Nakahara T, Uchi H, Hirota T, Tamari M, Shimizu N, Ebihara T, Amagai M, Furue M, Hayashi J, Kudoh J. Filaggrin loss-of-function mutations are not a predisposing factor for atopic dermatitis in an Ishigaki Island under subtropical climate. J Dermatol Sci. 2014; 76: 10–15.
15. Ballardini N, Kull I, Söderhäll C, Lilja G, Wickman M, Wahlgren CF. Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohort. Br J Dermatol 2013; 168: 588–594.
16. Trzeciak M1, Gleń J, Bandurski T, Sokołowska-Wojdyło M, Wilkowska A, Roszkiewicz J. Relationship between serum levels of interleukin-18, IgE and disease severity in patients with atopic dermatitis. Clin Exp Dermatol 2011; 36: 728–732.
17. Nakazato J, Kishida M, Kuroiwa R, Fujiwara J, Shimoda M, Shinomiya N. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatr Allergy Immunol 2008; 19: 605–613.
18. Leung TF, Ma KC, Hon KL, Lam CW, Wan H, Li CY, et al. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol 2003; 14: 296–301.
19. Hill DJ, Hosking CS, de Benedictis FM, Oranje AP, Diepgen TL, Bauchau V, et al. Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: An international study. Clin Exp Allergy 2008; 38: 161–168.